• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management.

作者信息

Kumar Nagi B

机构信息

Division of Population Sciences and Genitourinary and Breast Oncology Departments, H. Lee Moffitt Cancer Center & Research Institute, Inc, 12902 Magnolia Drive, MRC/CANCONT, Tampa, FL, 33612, USA.

出版信息

J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):519-522. doi: 10.1002/jcsm.12681. Epub 2021 Feb 7.

DOI:10.1002/jcsm.12681
PMID:33554483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013485/
Abstract
摘要

相似文献

1
Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management.新型冠状病毒肺炎相关恶病质是否类似于癌症相关恶病质？探究其机制、临床生物标志物及临床管理的潜在靶点。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):519-522. doi: 10.1002/jcsm.12681. Epub 2021 Feb 7.
2
Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19.癌症恶病质中的细胞因子和趋化因子及其对 COVID-19 的长期影响。
Cells. 2022 Feb 8;11(3):579. doi: 10.3390/cells11030579.
3
Cancer cachexia, recent advances, and future directions.癌症恶病质、最新进展及未来方向。
Cancer J. 2015 Mar-Apr;21(2):117-22. doi: 10.1097/PPO.0000000000000100.
4
Cancer cachexia: Diagnosis, assessment, and treatment.癌症恶病质：诊断、评估与治疗。
Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31.
5
On our way to targeted therapy for cachexia in cancer?我们正在通往癌症恶病质靶向治疗的道路上吗？
Curr Opin Oncol. 2006 Jul;18(4):335-40. doi: 10.1097/01.cco.0000228738.85626.ac.
6
Why is progress in treatment of cancer cachexia so slow?为什么癌症恶病质的治疗进展如此缓慢？
Lancet Oncol. 2007 Aug;8(8):671-2. doi: 10.1016/s1470-2045(07)70222-x.
7
Malignancy. Cancer cachexia.恶性肿瘤。癌症恶病质。
Br J Hosp Med. 1982 Jan;27(1):28-9, 33-4.
8
More research needed on the treatment of the cancer anorexia/cachexia syndrome.对于癌症厌食/恶病质综合征的治疗需要更多研究。
J Support Oncol. 2006 Nov-Dec;4(10):508-9.
9
Personalized, patient-centred cancer cachexia management: lessons to be learnt from oncology and to be taught to oncology.个性化、以患者为中心的癌症恶病质管理：肿瘤学的经验教训及肿瘤学应学习的内容。
Curr Opin Support Palliat Care. 2013 Dec;7(4):342-4. doi: 10.1097/SPC.0000000000000018.
10
Preface: cancer cachexia, from basic research to clinical application: a paradigmatic translational research journey.前言：癌症恶病质，从基础研究到临床应用：一段典型的转化研究历程。
Crit Rev Oncog. 2012;17(3):2 p following table of content. doi: 10.1615/critrevoncog.v17.i3.10.

引用本文的文献

1
The Co-Design/Co-Development and Evaluation of an Online Frailty Check Application for Older Adults: Participatory Action Research with Older Adults.老年人在线衰弱检查应用程序的共同设计/共同开发和评估：与老年人共同开展的行动研究。
Int J Environ Res Public Health. 2023 Jun 10;20(12):6101. doi: 10.3390/ijerph20126101.
2
Frequency and factors associated with sarcopenia prediction in adult and elderly patients hospitalized for COVID-19.因 COVID-19 住院的成年和老年患者中肌少症预测的频率和相关因素。
Exp Gerontol. 2022 Oct 15;168:111945. doi: 10.1016/j.exger.2022.111945. Epub 2022 Sep 5.
3
Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19.癌症恶病质中的细胞因子和趋化因子及其对 COVID-19 的长期影响。
Cells. 2022 Feb 8;11(3):579. doi: 10.3390/cells11030579.
4
COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.COVID-19 与周围神经系统。从大流行到疫苗时代的 2 年回顾。
J Peripher Nerv Syst. 2022 Mar;27(1):4-30. doi: 10.1111/jns.12482. Epub 2022 Mar 14.
5
Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.急性 COVID-19 患者和 COVID-19 后急性后遗症患者的骨骼肌改变。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):11-22. doi: 10.1002/jcsm.12896. Epub 2022 Jan 7.
6
Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2.营养保健品和草药通过靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）降低2019冠状病毒病（COVID-19）风险并改善其治疗效果
Biomedicines. 2021 Sep 18;9(9):1266. doi: 10.3390/biomedicines9091266.
7
COVID-19 and Myositis: What We Know So Far.COVID-19 与肌炎：目前我们所了解的。
Curr Rheumatol Rep. 2021 Jul 3;23(8):63. doi: 10.1007/s11926-021-01023-9.

本文引用的文献

1
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.新型冠状病毒肺炎中的细胞因子风暴：现有证据与治疗策略。
Front Immunol. 2020 Jul 10;11:1708. doi: 10.3389/fimmu.2020.01708. eCollection 2020.
2
Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.新冠病毒与肾素-血管紧张素系统：对老年人的影响
J Nutr Health Aging. 2020;24(7):699-704. doi: 10.1007/s12603-020-1403-7.
3
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019（COVID-19）的病理生理学、传播、诊断和治疗：综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
5
COVID-19: a major cause of cachexia and sarcopenia?新型冠状病毒肺炎：恶病质和肌肉减少症的主要病因？
J Cachexia Sarcopenia Muscle. 2020 Aug;11(4):863-865. doi: 10.1002/jcsm.12589. Epub 2020 Jun 9.
6
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.严重急性呼吸综合征冠状病毒 2 感染：细胞因子在 COVID-19 疾病中的作用。
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
7
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.冠状病毒与 ACE2、血管紧张素 II 和 RAS 抑制剂的相互作用——来自现有证据的教训和对 COVID-19 的深入了解。
Hypertens Res. 2020 Jul;43(7):648-654. doi: 10.1038/s41440-020-0455-8. Epub 2020 Apr 27.
8
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子（包括白细胞介素 6）在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
9
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.新型冠状病毒（COVI-19 或 SARS-CoV-2）诱导促炎细胞因子（IL-1 和 IL-6）和肺部炎症：抗炎策略。
J Biol Regul Homeost Agents. 2020;34(2):327-331. doi: 10.23812/CONTI-E.
10
Combining optimal nutrition and exercise in a multimodal approach for patients with active cancer and risk for losing weight: Rationale and practical approach.将最佳营养与运动相结合，采用多模式方法治疗活动期癌症且有体重减轻风险的患者：基本原理与实用方法。
Nutrition. 2019 Nov-Dec;67-68:110541. doi: 10.1016/j.nut.2019.06.022. Epub 2019 Jun 27.